Sarah Dyball

Sarah Dyball is an NIHR Academic Clinical Lecturer at the University of Manchester, working within the Centre for Musculoskeletal Research. Her clinical work is conducted at the Kellgren Centre for Rheumatology, which is a Lupus UK centre of Excellence.

Dr. Dyball's research focuses on systemic autoimmune rheumatic diseases (SARDs) including systemic lupus erythematosus (SLE), undifferentiated connective tissue disease (UCTD) and overlapping conditions. Her specific interests include patient-centered outcomes, clinical trial design, stratified/precision medicine, and real-world/observational data.

Analysis of Dr. Dyball's recent publications reveals a strong focus on lupus research, particularly examining patient experiences, treatment response patterns, and clinical trial methodologies. Her work frequently employs real-world data and precision medicine approaches to better understand and treat connective tissue diseases, with significant international collaboration evident across her publications.

Scientific Awards:

• MRC Clinical Pharmacology and Therapeutics Research Fellowship (2020)

Dr. Dyball completed integrated clinical and research training through the NIHR Academic Clinical Fellowship at the University of Manchester. She has been involved in significant research collaborations, as evidenced by her numerous co-authored publications across international teams. Her PhD thesis completed in 2024 focused on developing new taxonomies for connective tissue diseases using stratified medicine approaches.

She maintains active clinical practice at the Kellgren Centre for Rheumatology while conducting research that bridges clinical care and scientific investigation in autoimmune diseases, with work contributing to UN Sustainable Development Goals related to health and well-being.